At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 24 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 300
- Started
- 2024-11-29
- Last checked
- 2026-01
Plain English Summary
What is this study?
- • Testing a new treatment for cancer
- • Clinical study - 300 participants
- • There is a need to improve accessibility to research and clinical trials within the NHS
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with cancer
Where?
- • Liverpool - Clatterbridge Cancer Centre
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
There is a need to improve accessibility to research and clinical trials within the NHS. Key groups are consistently under-represented in research: those from minority ethnic backgrounds, those with lower socio-economic status and those with impaired capacity. This leads to inequality of healthcare and an inequality of patient experience. Increasing access to research would not only broaden research opportunities and bridge gaps in health equality; diverse research representation means better understanding of disease mechanisms and greater generalisability of findings across the patient population. There are well described socio-economic issues across the region that this trust serves within Cheshire and Merseyside. This brings health challenges for patients. Clatterbridge Cancer Centre is a large networked cancer centre serving Cheshire and Merseyside using a hub model. Research is a core strategic theme; it is hugely important that it is understood not only the areas and hotspots of cancer across the region, but also that patients with those cancers can access a portfolio of research that serves a distinct patient need. Currently there is a lack of such triangulated information within the Trust, which may mean that patient need remains unmet. Therefore the research is designed to understand any barriers that patients may have in accessing research, in tandem with a demographic review and mapping of patient referral and access to the current trials portfolio. This will lead to a truly patient centred approach in accessing research.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Adults over 18 years. No upper age limit
- ✓A confirmed diagnosis of cancer
- ✓Patient planned to or is receiving treatment at The Clatterbridge Cancer Centre NHS Foundation Trust
- ✓Able to provide agreement to take part
Who cannot take part
- ✗Patients with severe co-morbidities considered by the screening team to interfere with the individual's ability to...
See the full criteria
Where Is This Study? (1 UK site)
Clatterbridge Cancer Centre
Liverpool L7 8YA, United Kingdom